Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.22.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue:    
Products, services, other $ 480,000 $ 559,874
Total revenue 480,000 559,874
Costs and expenses:    
Cost of products and services 314,363 226,275
Research and development 281,589 299,943
Selling and marketing 66,462 93,328
General and administrative 903,885 1,015,430
Total operating costs and expenses 1,566,299 1,634,976
Operating loss (1,086,299) (1,075,102)
Other (expense) income:    
Interest expense, net (2,579,161) (4,668,064)
Unrealized (loss) gain on investment in equity securities 19,138 (107,903)
Loss on extinguishment of liabilities (589,850) (725,159)
Other income (expense) (3,513) (1,359)
Total other expense (3,153,386) (5,502,485)
Net loss (4,239,685) (6,577,587)
Deemed dividends on beneficial conversion feature (57,884)
Preferred stock dividends (432,149) (403,215)
Net loss attributable to common stockholders $ (4,671,834) $ (7,038,686)
Basic and diluted net loss per share attributable to common stockholders $ (0.48) $ (1.45)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 9,695,189 4,865,826